Beauty Right Introduces "Dietary Nutritional Supplement" with GLP-1 Active Peptide Capsules
April 22, 2024 08:00 ET
|
Beauty Right
New York, April 22, 2024 (GLOBE NEWSWIRE) -- Beauty Right, a brand specializing in dietary supplements, introduces GLP-1 Active Peptide Capsules, a nutritional supplement designed to help people...
Wholesale Weight Loss: Sesame Unveils Specialized Care for Weight Loss with Pricing Exclusively for Costco Members
April 02, 2024 10:59 ET
|
Sesame
NEW YORK CITY, April 02, 2024 (GLOBE NEWSWIRE) -- Sesame, the company building a radically new healthcare system for uninsured Americans and those with high-deductible plans, today unveiled an...
Noom Strengthens Commercial Leadership Team with Trio of Executive Healthcare Appointments
March 07, 2024 08:03 ET
|
Noom Inc
Jodi Bryant joins as President, Healthcare, Matt Moran as Chief Strategy Officer, and Cody Fair elevated to Chief Commercial Officer at Noom.
Noom Earns Highest CDC Recognition for Diabetes Prevention Program
March 05, 2024 08:47 ET
|
Noom Inc
The CDC Full Plus Recognition sets a new standard for digital health solutions providing metabolic health, chronic disease prevention, and weight loss.
NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation – ALT
February 19, 2024 16:53 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Altimmune,...
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation
January 05, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist
Zealand Pharma to highlight obesity pipeline at R&D Event on December 5
December 04, 2023 02:30 ET
|
Zealand Pharma
Press release – No. 16 / 2023 Zealand Pharma to highlight obesity pipeline at R&D Event on December 5 Event to be hosted by company management and feature key external scientific and...
Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023
October 31, 2023 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
Workplace Weight Loss & Wellness Program Unveiled
October 04, 2023 13:27 ET
|
Telegenixx
Telegenix's New Program Enables Employers to Provide Access to Pharma-Assisted Weight Loss at a Cost of $299 per Month, 70% Below the Industry Average
Structure Therapeutics Announces $300 Million Private Placement Equity Financing
September 29, 2023 07:32 ET
|
Structure Therapeutics Inc.
$300 million financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with existing cash, cash equivalents...